![Erik Chi-Lik Ng](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Erik Chi-Lik Ng
Chief Executive Officer at Xing Ling International Pte Ltd.
Network origin in Erik Chi-Lik Ng first degree
Entity | Entity type | Industry | |
---|---|---|---|
Novartis Corp.
![]() Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY.
18
| Subsidiary | Pharmaceuticals: Major | 18 |
Xing Ling International Pte Ltd.
![]() Xing Ling International Pte Ltd. Medical DistributorsDistribution Services Xing Ling International Pte Ltd. distributes Chinese and Western medicine. The company was founded in 2005 and is headquartered in Singapore.
2
| Private Company | Medical Distributors | 2 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Erik Chi-Lik Ng via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Credit Suisse Securities (USA) LLC (Broker)
![]() Credit Suisse Securities (USA) LLC (Broker) Investment Banks/BrokersFinance Credit Suisse Securities (USA) LLC (Credit Suisse Securities USA) is the broker/dealer division of Credit Suisse Securities (USA) LLC, an investment banking company headquartered in New York City. The firm was founded in 1998 and is a wholly owned subsidiary of Credit Suisse (USA), Inc., ultimately owned by Credit Suisse Group AG (SWX: CSGN) in Switzerland. Credit Suisse Securities USA offers a suite of equities, solutions and credit products and services which includes global securities sales, trading and execution, prime brokerage and comprehensive investment research. Their clients include financial institutions, corporations, governments, institutional investors, such as pension funds and hedge funds, and private individuals around the world. | Investment Banks/Brokers | Analyst-Equity | |
MERCK & CO., INC. | Pharmaceuticals: Major | Investor Relations Contact Corporate Officer/Principal | |
Rochester Christian University | College/University | Doctorate Degree | |
ARENA PHARMACEUTICALS | Pharmaceuticals: Major | Corporate Officer/Principal | |
IDENIX PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member | |
Medco Health Solutions, Inc.
![]() Medco Health Solutions, Inc. Medical/Nursing ServicesHealth Services Medco Health Solutions, Inc. retails drugs, pharmaceuticals and other health products through online. The firm provides pharmacy services which are designed for private and public employers, health plans, labor unions government agencies of all sizes and individuals. The company was founded in June 1983 and is headquartered in Franklin Lakes, NJ. | Medical/Nursing Services | Public Communications Contact | |
Cylene Pharmaceuticals, Inc.
![]() Cylene Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cylene Pharmaceuticals, Inc. discovers, develops and commercializes small molecule drugs. It develops molecule drugs to treat life-threatening diseases, with a particular emphasis in oncology. The firm drug discovery platform, STAND has delivered a diverse portfolio of drug candidates that target the multiple pathways critical for the support, maintenance of cancer cells and that address unmet medical needs with substantial markets. The company was founded in 1997 by Thomas James Farrell and Daniel Douglas Von Hoff and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member | |
Viridos, Inc.
![]() Viridos, Inc. Miscellaneous Commercial ServicesCommercial Services Viridos, Inc. develops and commercializes genomic-driven solutions and products. The firm's offerings are designed for application in solutions such as human health, food, water production, and environment. The company was founded by J. Craig Venter, Hamilton O. Smith, David C. Kiernan and Juan Enriquez-Cabot in February 2005 and is headquartered in La Jolla, CA. | Miscellaneous Commercial Services | Director/Board Member | |
REALM THERAPEUTICS PLC | Pharmaceuticals: Major | Director/Board Member | |
AILERON THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
FORMA Therapeutics, Inc.
![]() FORMA Therapeutics, Inc. BiotechnologyHealth Technology FORMA Therapeutics, Inc. discovers and develops medicines for cancer and other genetically driven diseases. Its drug discovery engine deploys screening and structure-based approaches across broad families of targets involved in tumor metabolism, epigenetics, protein homeostasis, and protein-protein interactions. The company was founded by Steven Tregay, Nikolai Kley, Stuart L. Schreiber, Todd R. Golub, Michael Foley and Alexis Borisy in 2008 and is headquartered in Watertown, MA. | Biotechnology | Director/Board Member | |
Aerpio Therapeutics, Inc.
![]() Aerpio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aerpio Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company focused on advancing innovative therapies for vascular diseases. The firm develops small molecules and monoclonal antibodies for the treatment of vascular disease and enhancement of wound healing. Its two lead programs include a tie-2 activator for diabetic macular edema and vascular leak, and a hypoxia-inducible factor 1-a stabilizer for wound healing and the treatment of inflammatory bowel disease. The company was founded by Joseph H. Gardner and Robert Shalwitz in 2011 and is headquartered in Cincinnati, OH. | Pharmaceuticals: Major | Director/Board Member | |
Angiocrine Bioscience, Inc.
![]() Angiocrine Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Angiocrine Bioscience, Inc. is a clinical-stage biotechnology company based on its novel and proprietary e-cel® platform. The company is based in San Diego, CA. The company is developing multiple e-cel therapies designed to repair damaged tissue from age-related degenerative disease of the musculoskeletal system, immune diseases that attack vessels and tissues, and ischemic diseases involving soft tissue, central nervous system, and the heart. The CEO of the company is Paul W. Finnegan. | Miscellaneous Commercial Services | Director/Board Member | |
NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal | |
National University of Singapore | College/University | Undergraduate Degree | |
Boston University | College/University | Undergraduate Degree | |
NEA Management Co. LLC
![]() NEA Management Co. LLC Investment ManagersFinance New Enterprise Associates LLC (New Enterprise Associates) is a venture capital firm founded in 1977. The firm headquartered in Menlo Park, California. | Investment Managers | Corporate Officer/Principal Corporate Officer/Principal | |
Tulane University (Louisiana) | College/University | Graduate Degree | |
ESBATech, a Novartis Co. GmbH
![]() ESBATech, a Novartis Co. GmbH Miscellaneous Commercial ServicesCommercial Services ESBATech AG develops antibody fragment therapeutics. The firm's antibody fragment is derived from human antibody fragment scaffolds. It develops Immuna, an antigen-independent platform to screen, select, and optimize highly-stable and soluble, single-chain antibody fragments. The company was founded by Dominik Escher in September 1998 and is headquartered Schlieren, Switzerland. | Miscellaneous Commercial Services | Director/Board Member | |
William Paterson University | College/University | Undergraduate Degree | |
INOVIO PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Genedata AG
![]() Genedata AG Packaged SoftwareTechnology Services Genedata AG transforms data into intelligence with a portfolio of advanced software solutions. Its products include biologics, screener, expressionist, profiler, analyst, phylosospher, selector, imagence and bioprocess. The firm offers data analysis, information technology, training, software, development and hosting services to pharmaceutical, agrochemical, Industrial biotechnology companies and non-profit research organizations. The company was founded by Othmar Pfannes in 1997 and is headquartered in Basel, Switzerland. | Packaged Software | Chairman | |
Novartis Venture Funds
![]() Novartis Venture Funds Investment ManagersFinance Novartis Venture Funds (NVF) is a venture capital firm with headquarters in Basel, Switzerland and an additional office in Cambridge, MA. The firm was founded in 1996. NVF is a subsidiary of Novartis AG (VX: NOVN) and was created following the 1996 merger of Ciba-Geigy and Sandoz. | Investment Managers | Private Equity Investor | |
University of Warwick | College/University | Masters Business Admin | |
University of Regensburg | College/University | Doctorate Degree | |
SYMETIS SA | Biotechnology | Director/Board Member | |
Novartis Bioventure Fund
![]() Novartis Bioventure Fund Investment ManagersFinance Novartis Bioventure Fund focuses on companies operating in the field of life science technology. The geographical focus includes the US, Canada, UK and Switzerland. The fund invests in biotechnology, pharmaceuticals and medical device products. It invests in all stages of financing and also invests in mezzanine transactions. | Investment Managers | President | |
TIGER AIRWAYS HOLDINGS LIMITED | Airlines | President | |
International Society for Biological Therapy of Cancer
![]() International Society for Biological Therapy of Cancer Miscellaneous Commercial ServicesCommercial Services The International Society for Biological Therapy of Cancer operates as a professional society of influential scientists, academicians, researchers, clinicians, and government representatives. The non-profit company is based in Milwaukee, WI. | Miscellaneous Commercial Services | President | |
Pearl Therapeutics, Inc.
![]() Pearl Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Pearl Therapeutics, Inc. develops therapies for the treatment of chronic respiratory diseases. It offers respiratory product development, high quality therapies for COPD, Asthma and treatment and prevention of chronic respiratory diseases and asthma. The company was founded in 2006 by Sarvajna Dwivedi and is headquartered in Redwood City, CA. | Pharmaceuticals: Major | Public Communications Contact | |
Novartis Pharma AG
![]() Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Novartis Pharma AG engages in the research in as well as the production and distribution of pharmaceutical, chemical, medical, and biotechnological products. It also provides related services. The company was founded on October 25, 1989 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | General Counsel Corporate Officer/Principal | |
Columbia University Medical Center | College/University | Corporate Officer/Principal | |
Weill Cornell Medical College | College/University | Doctorate Degree | |
Pharmaco LSR, Inc.
![]() Pharmaco LSR, Inc. Miscellaneous Commercial ServicesCommercial Services Pharmaco LSR, Inc. provides clinical research services. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Zanvyl Krieger School of Arts & Sciences | College/University | Undergraduate Degree | |
MOLECULIN BIOTECH, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
CNS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Refuge Biotechnologies, Inc.
![]() Refuge Biotechnologies, Inc. Miscellaneous Commercial ServicesCommercial Services Refuge Biotechnologies, Inc. develops therapeutic cells. It is leveraging gene engineering technologies known as CRISPR interference (CRISPRi) and CRISPR activation (CRISPRa) to develop therapeutic cells that are programmed to make decisions inside the patient’s body. The firms programs include RB-1916, RB-H21 and RB-M1. The company was founded by Stanley Qi, David R. Parkinson and Bing C. Wang and is headquartered in Menlo Park, CA. | Miscellaneous Commercial Services | Founder | |
AFFLUENT MEDICAL | Medical Specialties | Director/Board Member | |
ImmunOs Therapeutics AG
![]() ImmunOs Therapeutics AG BiotechnologyHealth Technology ImmunOs Therapeutics AG is a company based in Schlieren, Switzerland that pioneers HLA-based therapeutics to create transformational medicines for cancer and inflammation. The Swiss company has identified specific HLA molecules that activate the immune system and is utilizing these molecules as the backbone of novel therapies capable of stimulating both the innate and adaptive immune systems of cancer patients to eliminate tumor cells. ImmunOs' lead program is a multi-functional fusion protein that blocks specific LILRB and KIR receptors and activates anti-tumor responses. The company is also using HLA molecules to develop novel therapies to treat inflammatory diseases. ImmunOs is supported by leading international investors, including Samsara BioCapital, Lightspeed Venture Partners, Gimv, Pfizer Ventures, Biomed Partners, Schroder Adveq, Mission BioCapital, GL Capital, Peak6, Fiscus, and Redalpine. The company was founded by Osiris Marroquin Belaunzaran and Christoph Renner, and the CEO is Sean R. Smith. | Biotechnology | Chairman | |
Pierian Biosciences LLC
![]() Pierian Biosciences LLC Medical/Nursing ServicesHealth Services Pierian Biosciences LLC operates as a diagnostic development and laboratory service company. It offers ChemoINTEL, a functional multi-parametric chemosensitivity assay measuring the real-time kinetic molecular and morphologic apoptotic response in isolated tumor cells; and ImmunoINTEL, a flow cytometry-based platform delivering phenotypic characterization and quantitative functional interrogation of tumor and immune populations within a tumor sample and relevant tissues. The company is headquartered in Franklin, TN. | Medical/Nursing Services | Director/Board Member | |
Artidis AG
![]() Artidis AG Medical SpecialtiesHealth Technology Artidis AG develops nano mechanical biomarkers for rapid cancer diagnostics. The private company is based in Basel, Switzerland. The Swiss company was founded by Marija Plodinec, Marko Loparic, Philipp Oertle, Tobias Appenzeller. Marija Plodinec has been the CEO since incorporation. | Medical Specialties | Director/Board Member | |
Versameb AG
![]() Versameb AG Miscellaneous Commercial ServicesCommercial Services Versameb AG operates as an preclinical-stage biopharmaceutical company. The company was founded by Friedrich Metzger, Roger Meier and Urs Breitenstein in 2018 and is headquartered in Basel, Switzerland. | Miscellaneous Commercial Services | Chairman |
Statistics
International
United States | 34 |
Switzerland | 11 |
Singapore | 4 |
United Kingdom | 3 |
Germany | 2 |
Sectoral
Health Technology | 23 |
Consumer Services | 11 |
Commercial Services | 9 |
Finance | 6 |
Health Services | 3 |
Operational
Corporate Officer/Principal | 64 |
Director/Board Member | 55 |
President | 14 |
Independent Dir/Board Member | 12 |
Undergraduate Degree | 11 |
Most connected contacts
Insiders | |
---|---|
David Parkinson | 31 |
Reinhard Ambros | 20 |
John Kelly | 16 |
Rachel King | 14 |
Robert E. Pelzer | 12 |
Chadwick J. Orevillo | 10 |
Julian Lionel Sandt | 10 |
Vanessa Broadhurst | 9 |
Jean-Jacques Charhon | 9 |
James Caruso | 8 |
Sandra Silberman | 8 |
Patrick Gan | 7 |
A. Schobel | 7 |
John D. Menditto | 6 |
Lukas Scheibler | 6 |
- Stock Market
- Insiders
- Erik Chi-Lik Ng
- Company connections